|
CASC3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62658775337832E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.7601254615206E-12 |
| Normal-vs-Stage2 |
1.60374000000019E-05 |
| Normal-vs-Stage3 |
1.05360054014625E-10 |
| Normal-vs-Stage4 |
1.75059966522895E-10 |
| Stage1-vs-Stage2 |
5.331600E-01 |
| Stage1-vs-Stage3 |
1.007170E-01 |
| Stage1-vs-Stage4 |
5.910200E-02 |
| Stage2-vs-Stage3 |
8.546200E-02 |
| Stage2-vs-Stage4 |
6.716300E-02 |
| Stage3-vs-Stage4 |
6.899800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.76300024263321E-10 |
| Normal-vs-AfricanAmerican |
1.463170E-03 |
| Normal-vs-Asian |
5.6366000000807E-07 |
| Caucasian-vs-AfricanAmerican |
1.683350E-01 |
| Caucasian-vs-Asian |
6.079800E-01 |
| AfricanAmerican-vs-Asian |
4.017000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.36459962721369E-10 |
| Normal-vs-Female |
1.81754611361384E-12 |
| Male-vs-Female |
2.362400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.84180473492302E-11 |
| Normal-vs-Age(41-60Yrs) |
5.15043563353856E-12 |
| Normal-vs-Age(61-80Yrs) |
1.24870003226363E-09 |
| Normal-vs-Age(81-100Yrs) |
1.262070E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.838000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.058200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.248600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.619400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.813200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.636000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.62459999994724E-06 |
| Classical-VS-Follicular |
1.461820E-01 |
| Classical-VS-Other |
2.982800E-01 |
| Classical-VS-Normal |
4.71890000408592E-08 |
| Tall-VS-Follicular |
6.159800E-03 |
| Tall-VS-Other |
5.832600E-01 |
| Tall-VS-Normal |
2.25508500761862E-12 |
| Follicular-VS-Other |
6.223800E-01 |
| Follicular-VS-Normal |
1.14139997453577E-09 |
| Other-VS-Normal |
3.059400E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.90919527251776E-11 |
| Normal-vs-N1 |
3.63770125133556E-11 |
| N0-vs-N1 |
1.885590E-02 |
|
|
